Psychiatry Research: Neuroimaging
Volume 154, Issue 1 , Pages 49-58 , 15 January 2007

Abnormal glucose metabolism in the anterior cingulate cortex in patients with schizophrenia

  • Toshiro Fujimoto

      Affiliations

    • Department Psychiatry, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81 986 25 1313; fax: +81 986 25 3950.
    • ,
  • Kouzou Takeuch

      Affiliations

    • Fujimoto Hospital, Yokakai Foundation, 17-4, Hayasuzu-cho, Miyakonojo, 885-0055, Japan
    • Tel.: +81 986 25 1313; fax: +81 986 25 3950.
    • ,
  • Tetsuro Matsumoto

      Affiliations

    • Fujimoto Hospital, Yokakai Foundation, 17-4, Hayasuzu-cho, Miyakonojo, 885-0055, Japan
    • Tel.: +81 986 25 1313; fax: +81 986 25 3950.
    • ,
  • Kiyohisa Kamimura

      Affiliations

    • Fujimoto Hospital, Yokakai Foundation, 17-4, Hayasuzu-cho, Miyakonojo, 885-0055, Japan
    • Tel.: +81 986 25 1313; fax: +81 986 25 3950.
    • ,
  • Ryuichiro Hamada

      Affiliations

    • Fujimoto Hospital, Yokakai Foundation, 17-4, Hayasuzu-cho, Miyakonojo, 885-0055, Japan
    • Tel.: +81 986 25 1313; fax: +81 986 25 3950.
    • ,
  • Katsumi Nakamura

      Affiliations

    • Fujimoto Hospital, Yokakai Foundation, 17-4, Hayasuzu-cho, Miyakonojo, 885-0055, Japan
    • Tel.: +81 986 25 1313; fax: +81 986 25 3950.
    • ,
  • Nobumasa Kato

      Affiliations

    • Department Psychiatry, Faculty of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan

Received 28 November 2005 ,Revised 27 March 2006 ,Accepted 2 April 2006.

References 

  1. Bartlett EJ, Brodie JD, Simkowitz P, Dewey SL, Rusinek H, Wolf AP, et al. Effects of haloperidol challenge on regional cerebral glucose utilization in normal human subjects. American Journal of Psychiatry. 1994;151:681–686
  2. Bartley AJ, Jones DW, Weinberger DR. Genetic variability of human brain size and cortical gyral patterns. Brain. 1997;120:257–269
  3. Benes FM. Model generation and testing to probe neural circuitry in the cingulate cortex of postmortem schizophrenic brain. Schizophrenia Bulletin. 1998;24:219–230
  4. Benes FM, Davidson J, Bird ED. Quantitative cytoarchitectural studies of the cerebral cortex of schizophrenics. Archives of General Psychiatry. 1986;43:31–35
  5. Benes FM, Vincent SL, Alsterberg G, Bird ED, SanGiovanni JP. Increased GABAA receptor binding in superficial layers of cingulate cortex in schizophrenics. Journal of Neuroscience. 1992;12:924–929
  6. Buchsbaum MS, Hazlett EA. Functional brain imaging and aging in schizophrenia. Schizophrenia Research. 1997;27:129–141
  7. Buchsbaum MS, Hazlett EA. Positron emission tomography studies of abnormal glucose metabolism in schizophrenia. Schizophrenia Bulletin. 1998;24:343–364
  8. Buchsbaum MS, Ingvar DH, Kessler R, Waters RN, Cappelletti J, van Kammen DP, et al. Cerebral glucography with positron tomography: use in normal subjects and in patients with schizophrenia. Archives of General Psychiatry. 1982;39:251–259
  9. Buchsbaum MS, DeLisi LE, Holcomb HH, Cappelletti J, King AC, Johnson J, et al. Anteroposterior gradients in cerebral glucose use in schizophrenia and affective disorders. Archives of General Psychiatry. 1984;41:1159–1166
  10. Buchsbaum MS, Wu JC, DeLisi LE, Holcomb HH, Hazlett E, Cooper-Langston K, et al. Positron emission tomography study of basal ganglia and somatosensory cortex neuroleptic drug effects: differences between normal controls and schizophrenic patients. Biological Psychiatry. 1987;22:479–494
  11. Buchsbaum MS, Haier RJ, Potkin SG, Nuechterlein K, Bracha HS, Katz M, et al. Frontostriatal disorder of cerebral metabolism in never-medicated schizophrenics. Archives of General Psychiatry. 1992;49:935–942
  12. Buchsbaum MS, Potkin SG, Siegel BV, Lohr J, Katz M, Gottschalk LA, et al. Striatal metabolic rate and clinical response to neuroleptics in schizophrenia. Archives of General Psychiatry. 1992;49:966–974
  13. Burdette JH, Minoshima S, Borght TV, Tran DD, Kuhl DE. Alzheimer disease: improved visual interpretation of PET images by using three-dimensional stereotaxic surface projections. Radiology. 1996;198:837–843
  14. Bush G, Luu P, Posner MI. Cognitive and emotional influences in anterior cingulate cortex. Trends in Cognitive Sciences. 2000;4:215–222
  15. Bush G, Shin LM, Holmes J, Rosen BR, Vogt BA. The multi-source interference task: validation study with fMRI in individual subjects. Molecular Psychiatry. 2003;8:60–70
  16. DeLisi LE, Holcomb HH, Cohen RM, Pickar D, Carpenter W, Morihisa JM, et al. Positron emission tomography in schizophrenic patients with and without neuroleptic medication. Journal of Cerebral Blood Flow and Metabolism. 1985;5:201–206
  17. Dolan RJ, Fletcher P, Frith CD, Friston KJ, Frackowiak RSJ, Grasby PM. Dopaminergic modulation of impaired cognitive activation in the anoterior cingulate cortex in schizophrenia. Nature. 1995;378:180–182
  18. Farkas T, Wolf AP, Jaeger J, Brodie JD, Christman DR, Fowler JS. Regional brain glucose metabolism in chronic schizophrenia. Archives of General Psychiatry. 1984;41:293–300
  19. Fletcher P, McKenna PJ, Friston KJ, Frith CD, Dolan RJ. Abnormal cingulate modulation of fronto–temporal connectivity in schizophrenia. Neuroimage. 1999;9:337–342
  20. Flor-Henry P. Cerebral Basis of Psychopathology. USA: John Wright-PSG Inc.; 1983;
  21. Geschwind N, Galaburda AM. Cerebral lateralization: biological mechanisms, associations, and pathology: II. A hypothesis and a program for research. Archives of Neurology. 1985;42:521–552
  22. Goldstein JM, Goodman JM, Seidman LJ, Kennedy DN, Makris N, Lee H, et al. Cortical abnormalities in schizophrenia identified by structural magnetic resonance imaging. Archives of General Psychiatry. 1999;56:537–547
  23. Goldstein JM, Seidman LJ, O'Brien LM, Horton NJ, Kennedy DN, Makris N, et al. Impact of normal sexual dimorphisms on sex differences in structural brain abnormalities in schizophrenia assessed by magnetic resonance imaging. Archives of General Psychiatry. 2002;59:154–164
  24. Holcomb HH, Cascella NG, Thaker GK, Medoff DR, Dannals RF, Tamminga CA. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. American Journal of Psychiatry. 1996;153:41–49
  25. Häfner H. Gender differences in schizophrenia. Psychoneuroendocrinology. 2003;28:17–54
  26. Katz M, Buchsbaum MS, Siegel BV, Wu J, Haier RJ, Bunney WE. Correlational patterns of cerebral glucose metabolism in never-medicated schizophrenics. Neuropsychobiology. 1996;33:1–11
  27. Kling AS, Metter EJ, Riege WH, Kuhl DE. Comparison of PET measurement of local brain glucose metabolism and CAT measurement of brain atrophy in chronic schizophrenia and depression. American Journal of Psychiatry. 1986;143:175–180
  28. Lahti AC, Holcomb HH. Schizophrenia, VIII. American Journal of Psychiatry. 2003;160:2091
  29. Liddle PF, Friston KJ, Frith CD, Hirsch SR, Jones T, Frackowiak RSJ. Patterns of cerebral blood flow in schizophrenia. British Journal of Psychiatry. 1992;160:179–186
  30. Minoshima S. Imaging Alzheimer's disease: clinical applications. Neuroimaging Clinics of North America. 2003;13:769–780
  31. Minoshima S, Frey KA, Koeppe RA, Foster NL, Kuhl DE. A diagnostic approach in Alzheimer's disease using three-dimensional stereotactic surface projections of fluorine-18-FDG PET. Journal of Nuclear Medicine. 1995;36:1238–1248
  32. Minoshima S, Ficaro EP, Frey KA, Koeppe RA, Kuhl DE. Data extraction from brain PET images using three-dimensional stereotactic surface projections. In:  Myers R,  Cunningham V,  Bailey D,  Jones T editor. Quantification of Brain Function Using PET. San Diego: Academic Press; 1998;p. 133–137
  33. Molina V, Sanz J, Sarramea F, Luque R, Benito C, Palomo T. Dorsolateral prefrontal and superior temporal volume deficits in first-episode psychoses that evolve into schizophrenia. European Archives of Psychiatry and Clinical Neuroscience. 2006;256:106–111
  34. Ngan ETC, Lane CJ, Ruth TJ, Liddle PF. Immediate and delayed effects of risperidone on cerebral metabolism in neuroleptic naïve schizophrenic patients: correlations with symptom change. Journal of Neurology, Neurosurgery and Psychiatry. 2002;72:106–110
  35. Seeman MV, Lang M. The role of estrogens in schizophrenia gender differences. Schizophrenia Bulletin. 1990;16:185–194
  36. Soyka M, Koch W, Möller HJ, Rüther T, Tatsch K. Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients: results from a FDG-PET study. European Archives of Psychiatry and Clinical Neuroscience. 2005;255:308–312
  37. Szechtman H, Nahmias C, Garnett ES, Firnau G, Brown GM, Kaplan RD, et al. Effect of neuroleptics on altered cerebral glucose metabolism in schizophrenia. Archives of General Psychiatry. 1988;45:523–532
  38. Talairach J, Tournoux P. Co-Planar Stereotaxic Atlas of the Human Brain. New York: Thieme Medical Publishers Inc.; 1988;
  39. Vogt BA, Nimchinsky EA, Vogt LJ, Hof PR. Human cingulate cortex: surface features, flat maps, and cytoarchitecture. Journal of Comparative Neurology. 1995;359:490–506
  40. Vollenweider FX, Leenders KL, Scharfetter C, Antonini A, Maguire P, Missimer J, et al. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and [18F]fluorodeoxyglucose (FDG). European Neuropsychopharmacology. 1997;7:9–24
  41. Wolkin A, Jaeger J, Brodie JD, Wolf AP, Fowler J, Rotrosen J, et al. Persistence of cerebral metabolic abnormalities in chronic schizophrenia as determined by positron emission tomography. American Journal of Psychiatry. 1985;142:564–571
  42. Yücel M, Stuart GW, Maruff P, Wood SJ, Savage GR, Smith DJ, et al. Paracingulate morphologic differences in males with established schizophrenia: a magnetic resonance imaging morphometric study. Biological Psychiatry. 2002;52:15–23

PII: S0925-4927(06)00064-3

doi: 10.1016/j.pscychresns.2006.04.002

Psychiatry Research: Neuroimaging
Volume 154, Issue 1 , Pages 49-58 , 15 January 2007

Article Tools

* Image Usage & Resolution